Skip to main content
OpenTrials

Clinical trial condition

Anemia, Hemolytic

Explore clinical trials studying Anemia, Hemolytic. Study availability and eligibility vary by location and protocol.

1,383 public trials 241 recruiting studies
Refine in advanced search Browse all conditions

Anemia, Hemolytic trial results

Active, Not Recruiting

A Prospective, Non-interventional, Observational Study of Presentation, Treatment Patterns and Outcomes in Atypical Hemolytic Uremic Syndrome Patients

NCT06099236

Conditions
Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +15 more
Locations
  • Research Site Beijing, Beijing Municipality, China
  • Research Site Chongqing, Sichuan, China
  • Research Site Anhui, China
  • Research Site Beijing, China
View all 26 locations
View Trial Details
Active, Not Recruiting

Safety and Efficacy Evaluation of BRL-101 in Subjects With Transfusion-Dependent β-Thalassemia

NCT05577312

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
Locations
  • Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China
  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen Universit Guanzhou, Guangdong, China
  • Shenzhen Children 's Hospital Shenzhen, Guangdong, China
  • No. 923 Hospital of Joint Support Force of Chinese People 's Liberation Army Hospital Nanning, Guangxi, China
View Trial Details
Active, Not Recruiting

A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)

NCT04861259

Conditions
Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +14 more
Locations
  • Univ of CA San Francisco San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Emory Children's Center Atlanta, Georgia, United States
  • Washington University St Louis, Missouri, United States
View all 42 locations
View Trial Details
Active, Not Recruiting

Long-term Safety and Tolerability of Iptacopan in Patients With Paroxysmal Nocturnal Hemoglobinuria

NCT04747613

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • City Of Hope National Med Center Duarte, California, United States
  • City Of Hope Duarte, California, United States
  • USC Norris Cancer Center Los Angeles, California, United States
  • Univ Cali Irvine ALS Neuromuscular Orange, California, United States
View all 60 locations
View Trial Details
Active, Not Recruiting

Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients

NCT03814746

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +9 more
Locations
  • Childrens Healthcare of Atlanta Atlanta, Georgia, United States
  • Boston Medical Center Boston, Massachusetts, United States
  • Levine Cancer Insitute Carolinas Healthcare System Charlotte, North Carolina, United States
  • Univ of Tenn Health Sciences Ctr Memphis, Tennessee, United States
View all 59 locations
View Trial Details
Active, Not Recruiting

CINC424A2X01B Rollover Protocol

NCT02386800

Conditions
Acute Myeloid Leukemia, Anemia, Anemia, Hemolytic, +31 more
Locations
  • Novartis Investigative Site Darlinghurst, New South Wales, Australia
  • Novartis Investigative Site Herston, Queensland, Australia
  • Novartis Investigative Site Wooloongabba, Queensland, Australia
  • Novartis Investigative Site Bedford Park, South Australia, Australia
View all 97 locations
View Trial Details
Active, Not Recruiting

Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Severe Sickle Cell Disease (SCD)

NCT05329649

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +10 more
Locations
  • Levine Children's Hospital - Hematology Charlotte, North Carolina, United States
  • The Children's Hospital of Philadelphia - Hematology Philadelphia, Pennsylvania, United States
  • St. Jude Children's Research Hospital Memphis, Tennessee, United States
  • TriStar Medical Group Children's Specialists - Pediatric Oncology Nashville, Tennessee, United States
View Trial Details

Related conditions